MyFinsight
Home
Blog
About
Proceeds from issuance of
common stock and...
$69,000K
Proceeds from issuance of
common stock related to...
$2K
Net cash provided by
(used in) financing...
$64,470K
Canceled cashflow
$4,532K
Net increase
(decrease) in cash, cash...
$42,215K
Canceled cashflow
$22,255K
Payment of debt and
equity offering costs
$4,532K
Stock-based compensation
expense
$871K
Depreciation and
amortization
$631K
Non-cash lease expense
$72K
Net cash used in
operating activities
-$22,120K
Net cash used in
investing activities
-$135K
Canceled cashflow
$1,574K
Net loss
-$16,229K
Prepaid expenses and
other current assets
$3,907K
Accounts payable
-$1,434K
Other assets
$833K
Purchases of property and
equipment
$135K
Change in fair value of
warrant and conversion...
-$615K
Accrued expenses and
other current...
-$589K
Other liabilities
-$87K
Back
Back
Cash Flow
SPRUCE BIOSCIENCES, INC. (SPRB)
SPRUCE BIOSCIENCES, INC. (SPRB)
source: myfinsight.com